FIELD: medicine, cellular immunology. SUBSTANCE: method involves increase of number of C 34+ cells in cellular population (in culture) by interaction of cellular population (for example, hemopoietic cells) with antibody, for example, CP3/43. Antibody can be used in combination with alkylating agent, for example, cyclophosphamide. EFFECT: broadened arsenal of agents used for treatment of patients with immune system diseases. 20 cl, 20 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING UNDIFFERENTIATED CELL | 1996 |
|
RU2215539C2 |
TREATMENT WITH APPLICATION OF PRE-PROGRAMMED MATURE AND DIFFERENTIATED CELLS | 2009 |
|
RU2635317C2 |
METHOD FOR DETERMINING SUBPOPULATION COMPOSITION OF SKIN CELLS AND OBTAINING SKIN CYTOIMMUNOGRAM | 2016 |
|
RU2630607C1 |
MODEL OF HLA-INCOMPATIBLE HUMANIZED NSG MOUSE WITH XENOGRAFT OBTAINED FROM A PATIENT | 2016 |
|
RU2757421C2 |
NEW SUBPOPULATION OF TREG CD8CD45RC CELLS AND ITS APPLICATIONS | 2016 |
|
RU2766691C2 |
METHODS OF OBTAINING CELLS, DEMONSTRATING PHENOTYPIC PLASTICITY | 2010 |
|
RU2536941C2 |
COMPOSITION (VERSIONS), METHOD AND ASSEMBLY FOR SEPARATING CELLS | 2003 |
|
RU2346039C2 |
METHOD FOR DETECTING THE FREQUENCY OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES BEING MUTANT BY T-CELL RECEPTOR | 2006 |
|
RU2316766C1 |
CENTRAL MEMORY VETO ANTIVIRAL CELLS CD8+ IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION | 2020 |
|
RU2834894C2 |
COMBINATION THERAPY FOR STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B-CELL DEPLETION | 2012 |
|
RU2648354C2 |
Authors
Dates
2002-01-10—Published
1996-01-31—Filed